Glucobel

Glucobel SA is a Belgian medical technology company focused on the development of implantable, flexible glucose monitoring systems for patients with diabetes. The company is part of a cluster of innovation-driven entities, including Nyxoah and Cephalix, that share a proprietary platform for flexible neuro-stimulation and sensing. Glucobel's technology aims to provide a minimally invasive, long-term solution for continuous glucose monitoring, reducing the need for frequent external sensor replacements or finger-prick tests. Based in Mont-Saint-Guibert, the company operates under a multiparty intellectual property agreement and is led by experienced medtech entrepreneurs and inventors.